Aralez Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Aralez Pharma (ARLZ) Misses Q1 EPS by 2c
May 9, 2017 7:11 AM EDTAralez Pharma (NASDAQ: ARLZ) reported Q1 EPS of ($0.42), $0.02 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $26 million versus the consensus estimate of $21 million.
"We are pleased to report a solid first quarter of 2017, together with important... More
